New agentic functionality is designed to support capital planning decisions and inventory management for health systems.
TRIMEDX announced the addition of agentic AI-based capital planning and inventory optimization capabilities to TRIMEDX-AIQ, its clinical asset intelligence platform. The new functionality is intended to support capital and operating expense decision-making by combining a conversational AI agent with asset data to model scenarios related to capital planning and inventory use.
With most medical equipment utilized only 40–50% of the time and approximately 25% of capital budgets allocated to clinical assets, health systems face risk of over-purchasing, early replacement, and underutilized inventory, according to a release from the company. Traditional capital planning processes, the company says, “limit healthcare leaders’ ability to confidently validate purchase requests, adapt plans as conditions change, or identify opportunities to defer or avoid unnecessary spend.”
The new agentic AI capabilities within TRIMEDX-AIQ are designed to address these challenges by enabling more dynamic analysis and scenario planning for capital inventory decisions. Based on early modeling, TRIMEDX reports that organizations using the agentic capital planning and inventory optimization features may achieve:
- 25–35% capital expense avoidance or deferral
- 10–20% operating expense savings
- More flexible, maturity-aligned capital plans that evolve as clinical, operational, and financial priorities change
Through a conversational interface, users can interact with TRIMEDX-AIQ as it analyzes organizational data to identify trends and generate capital planning scenarios based on factors such as budget constraints, utilization levels, asset age, and service history. The AI agent is designed to compare multiple scenarios to support decision-making and planning discussions.
TRIMEDX says the platform evaluates inventory using data drawn from more than 6.1 million medical device records and analyzes factors including utilization, service history, cybersecurity status, and parts availability, using national benchmarks derived from its clinical asset dataset. According to the company, this analysis can help health systems identify opportunities to reallocate equipment, defer replacement, adjust inventory levels, or remove underperforming devices.
“Capital planning has historically been reactive and resource-intensive,” says Neil de Crescenzo, CEO of TRIMEDX, in a release. “By embedding agentic capital planning and inventory optimization into TRIMEDX-AIQ, we’re enabling health systems to move from static plans to continuously informed decisions.”
The company says the new capabilities expand TRIMEDX-AIQ’s role in supporting clinical asset decision-making related to utilization, inventory management, and capital planning.
ID 400507245 © Andrii Yalanskyi | Dreamstime.com
